Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy
To access this article, please choose from the options below
DISCLOSURE:The following authors disclosed financial relationships relevant to this publication: B.D. Greenwald: Research grant from, consultant for, and advisory committee member of CSA Medical. J.A. Dumot: Research grant from and advisory committee member of CSA Medical. C.J. Lightdale: Advisory committee member of CSA Medical. N.J. Shaheen: Research grant from, consultant for, and advisory committee member of CSA Medical; research grant from BÂRRX Medical Inc; research grant from, consultant for, and speaker for Proctor & Gamble; research grant from Oncoscope Inc; research grant from and consultant for Takeda Pharmaceuticals. All other authors disclosed no financial relationships relevant to this publication. CSA Medical supported this study through a grant for statistical analysis and by assisting in data collection at some sites. CSA Medical had no role in study design, analysis, interpretation of the data, or in writing the report.
PII: S0016-5107(10)00056-8
doi:10.1016/j.gie.2010.01.042
© 2010 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
Refers to article:
-
Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia
